Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Hematologic NeoplasmsCombined Modality TherapyBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsGraft vs Host DiseaseBusulfanHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideHematopoiesisSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHodgkin DiseaseCord Blood Stem Cell TransplantationDisease-Free SurvivalTransplantation ChimeraTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationSurvival AnalysisInfectionLymphoma, T-CellTime FactorsDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteVidarabineTransplantation, IsogeneicLeukemiaDexamethasoneRecombinant ProteinsBlood Cell CountFollow-Up StudiesBlood CellsAntineoplastic AgentsBone Marrow PurgingLymphomaCytomegalovirus InfectionsGraft vs Leukemia EffectProspective StudiesFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousBone MarrowLiver TransplantationLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearHematologic DiseasesHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsCyclosporinePrognosisFlow CytometryBlood DonorsCell SeparationImmunosuppressionBreast Neoplasms